Dorset Gastroenterology Limited 12255130 false 2023-11-01 2024-10-31 2024-10-31 The principal activity of the company is Specialists medical practice activities Digita Accounts Production Advanced 6.30.9574.0 true 12255130 2023-11-01 2024-10-31 12255130 2024-10-31 12255130 core:CurrentFinancialInstruments core:WithinOneYear 2024-10-31 12255130 bus:Micro-entities 2023-11-01 2024-10-31 12255130 bus:AuditExemptWithAccountantsReport 2023-11-01 2024-10-31 12255130 bus:FilletedAccounts 2023-11-01 2024-10-31 12255130 bus:SmallCompaniesRegimeForAccounts 2023-11-01 2024-10-31 12255130 bus:RegisteredOffice 2023-11-01 2024-10-31 12255130 bus:Director1 2023-11-01 2024-10-31 12255130 bus:Director2 2023-11-01 2024-10-31 12255130 bus:PrivateLimitedCompanyLtd 2023-11-01 2024-10-31 12255130 countries:EnglandWales 2023-11-01 2024-10-31 12255130 2022-11-01 2023-10-31 12255130 2023-10-31 12255130 core:CurrentFinancialInstruments core:WithinOneYear 2023-10-31 iso4217:GBP xbrli:pure

Registration number: 12255130

Dorset Gastroenterology Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 October 2024

 

Dorset Gastroenterology Limited

(Registration number: 12255130)
Balance Sheet as at 31 October 2024

2024
£

2023
£

Fixed assets

247,039

249,744

Current assets

10,194

17,016

Creditors: Amounts falling due within one year

(215,011)

(239,098)

Net current liabilities

(204,817)

(222,082)

Total assets less current liabilities

42,222

27,662

Accruals and deferred income

(3,720)

(3,432)

 

38,502

24,230

Capital and reserves

38,502

24,230

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
58 Kinson Road
Bournemouth
Dorset
BH10 4AN
UK

These financial statements were authorised for issue by the Board on 29 July 2025.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

The financial statements are prepared in sterling which is the functional currency of the company and rounded to the nearest £1.

2

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2023: 2).

 

Dorset Gastroenterology Limited

(Registration number: 12255130)
Balance Sheet as at 31 October 2024 (continued)

For the financial year ending 31 October 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 29 July 2025 and signed on its behalf by:
 

.........................................
Mrs L Sharer
Director

.........................................
Mr N M Sharer
Director